Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
- Autores
- Dominguez Meijide, Antonio; Parrales, Valeria; Vasili, Eftychia; González Lizarraga, Maria Florencia; König, Annekatrin; Lázaro, Diana F.; Lannuzel, Annie; Haik, Stéphane; del Bel Belluz Guimaraes, Elaine; Chehin, Rosana Nieves; Raisman Vozari, Rita; Michel, Patrick P.; Bizat, Nicolas; Outeiro, Tiago Fleming
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are neurodegenerative disorders characterized by the misfolding and aggregation of alpha-synuclein (aSyn). Doxycycline, a tetracyclic antibiotic shows neuroprotective effects, initially proposed to be due to its anti-inflammatory properties. More recently, an additional mechanism by which doxycycline may exert its neuroprotective effects has been proposed as it has been shown that it inhibits amyloid aggregation. Here, we studied the effects of doxycycline on aSyn aggregation in vivo, in vitro and in a cell free system using real-time quaking induced conversion (RT-QuiC). Using H4, SH-SY5Y and HEK293 cells, we found that doxycycline decreases the number and size of aSyn aggregates in cells. In addition, doxycycline inhibits the aggregation and seeding of recombinant aSyn, and attenuates the production of mitochondrial-derived reactive oxygen species. Finally, we found that doxycycline induces a cellular redistribution of aggregates in a C.elegans animal model of PD, an effect that is associated with a recovery of dopaminergic function. In summary, we provide strong evidence that doxycycline treatment may be an effective strategy against synucleinopathies.
Fil: Dominguez Meijide, Antonio. Universidad de Santiago de Compostela; España
Fil: Parrales, Valeria. Sorbonne University; Francia
Fil: Vasili, Eftychia. University Medical Center Goettingen; Alemania
Fil: González Lizarraga, Maria Florencia. Universidad Nacional de Tucumán. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucumán. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario; Argentina
Fil: König, Annekatrin. University Medical Center Goettingen; Alemania
Fil: Lázaro, Diana F.. University Medical Center Goettingen; Alemania
Fil: Lannuzel, Annie. Sorbonne University; Francia
Fil: Haik, Stéphane. Sorbonne University; Francia
Fil: del Bel Belluz Guimaraes, Elaine. Universidade de Sao Paulo; Brasil
Fil: Chehin, Rosana Nieves. Universidad Nacional de Tucumán. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucumán. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario; Argentina
Fil: Raisman Vozari, Rita. Sorbonne University; Francia
Fil: Michel, Patrick P.. Sorbonne University; Francia
Fil: Bizat, Nicolas. Sorbonne University; Francia
Fil: Outeiro, Tiago Fleming. University Medical Center Goettingen; Alemania - Materia
-
AGGREGATION
ALPHA-SYNUCLEIN
C. ELEGANS
DOXYCYCLINE
PARKINSON'S DISEASE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/172383
Ver los metadatos del registro completo
id |
CONICETDig_31b03eeca85a289dbb6306c96c0916ec |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/172383 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivoDominguez Meijide, AntonioParrales, ValeriaVasili, EftychiaGonzález Lizarraga, Maria FlorenciaKönig, AnnekatrinLázaro, Diana F.Lannuzel, AnnieHaik, Stéphanedel Bel Belluz Guimaraes, ElaineChehin, Rosana NievesRaisman Vozari, RitaMichel, Patrick P.Bizat, NicolasOuteiro, Tiago FlemingAGGREGATIONALPHA-SYNUCLEINC. ELEGANSDOXYCYCLINEPARKINSON'S DISEASEhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are neurodegenerative disorders characterized by the misfolding and aggregation of alpha-synuclein (aSyn). Doxycycline, a tetracyclic antibiotic shows neuroprotective effects, initially proposed to be due to its anti-inflammatory properties. More recently, an additional mechanism by which doxycycline may exert its neuroprotective effects has been proposed as it has been shown that it inhibits amyloid aggregation. Here, we studied the effects of doxycycline on aSyn aggregation in vivo, in vitro and in a cell free system using real-time quaking induced conversion (RT-QuiC). Using H4, SH-SY5Y and HEK293 cells, we found that doxycycline decreases the number and size of aSyn aggregates in cells. In addition, doxycycline inhibits the aggregation and seeding of recombinant aSyn, and attenuates the production of mitochondrial-derived reactive oxygen species. Finally, we found that doxycycline induces a cellular redistribution of aggregates in a C.elegans animal model of PD, an effect that is associated with a recovery of dopaminergic function. In summary, we provide strong evidence that doxycycline treatment may be an effective strategy against synucleinopathies.Fil: Dominguez Meijide, Antonio. Universidad de Santiago de Compostela; EspañaFil: Parrales, Valeria. Sorbonne University; FranciaFil: Vasili, Eftychia. University Medical Center Goettingen; AlemaniaFil: González Lizarraga, Maria Florencia. Universidad Nacional de Tucumán. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucumán. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario; ArgentinaFil: König, Annekatrin. University Medical Center Goettingen; AlemaniaFil: Lázaro, Diana F.. University Medical Center Goettingen; AlemaniaFil: Lannuzel, Annie. Sorbonne University; FranciaFil: Haik, Stéphane. Sorbonne University; FranciaFil: del Bel Belluz Guimaraes, Elaine. Universidade de Sao Paulo; BrasilFil: Chehin, Rosana Nieves. Universidad Nacional de Tucumán. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucumán. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario; ArgentinaFil: Raisman Vozari, Rita. Sorbonne University; FranciaFil: Michel, Patrick P.. Sorbonne University; FranciaFil: Bizat, Nicolas. Sorbonne University; FranciaFil: Outeiro, Tiago Fleming. University Medical Center Goettingen; AlemaniaAcademic Press Inc Elsevier Science2021-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/172383Dominguez Meijide, Antonio; Parrales, Valeria; Vasili, Eftychia; González Lizarraga, Maria Florencia; König, Annekatrin; et al.; Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo; Academic Press Inc Elsevier Science; Neurobiology of Disease; 151; 4-2021; 1-190969-99611095-953XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.nbd.2021.105256info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S096999612100005Xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:59:32Zoai:ri.conicet.gov.ar:11336/172383instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:59:32.53CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo |
title |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo |
spellingShingle |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo Dominguez Meijide, Antonio AGGREGATION ALPHA-SYNUCLEIN C. ELEGANS DOXYCYCLINE PARKINSON'S DISEASE |
title_short |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo |
title_full |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo |
title_fullStr |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo |
title_full_unstemmed |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo |
title_sort |
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo |
dc.creator.none.fl_str_mv |
Dominguez Meijide, Antonio Parrales, Valeria Vasili, Eftychia González Lizarraga, Maria Florencia König, Annekatrin Lázaro, Diana F. Lannuzel, Annie Haik, Stéphane del Bel Belluz Guimaraes, Elaine Chehin, Rosana Nieves Raisman Vozari, Rita Michel, Patrick P. Bizat, Nicolas Outeiro, Tiago Fleming |
author |
Dominguez Meijide, Antonio |
author_facet |
Dominguez Meijide, Antonio Parrales, Valeria Vasili, Eftychia González Lizarraga, Maria Florencia König, Annekatrin Lázaro, Diana F. Lannuzel, Annie Haik, Stéphane del Bel Belluz Guimaraes, Elaine Chehin, Rosana Nieves Raisman Vozari, Rita Michel, Patrick P. Bizat, Nicolas Outeiro, Tiago Fleming |
author_role |
author |
author2 |
Parrales, Valeria Vasili, Eftychia González Lizarraga, Maria Florencia König, Annekatrin Lázaro, Diana F. Lannuzel, Annie Haik, Stéphane del Bel Belluz Guimaraes, Elaine Chehin, Rosana Nieves Raisman Vozari, Rita Michel, Patrick P. Bizat, Nicolas Outeiro, Tiago Fleming |
author2_role |
author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
AGGREGATION ALPHA-SYNUCLEIN C. ELEGANS DOXYCYCLINE PARKINSON'S DISEASE |
topic |
AGGREGATION ALPHA-SYNUCLEIN C. ELEGANS DOXYCYCLINE PARKINSON'S DISEASE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are neurodegenerative disorders characterized by the misfolding and aggregation of alpha-synuclein (aSyn). Doxycycline, a tetracyclic antibiotic shows neuroprotective effects, initially proposed to be due to its anti-inflammatory properties. More recently, an additional mechanism by which doxycycline may exert its neuroprotective effects has been proposed as it has been shown that it inhibits amyloid aggregation. Here, we studied the effects of doxycycline on aSyn aggregation in vivo, in vitro and in a cell free system using real-time quaking induced conversion (RT-QuiC). Using H4, SH-SY5Y and HEK293 cells, we found that doxycycline decreases the number and size of aSyn aggregates in cells. In addition, doxycycline inhibits the aggregation and seeding of recombinant aSyn, and attenuates the production of mitochondrial-derived reactive oxygen species. Finally, we found that doxycycline induces a cellular redistribution of aggregates in a C.elegans animal model of PD, an effect that is associated with a recovery of dopaminergic function. In summary, we provide strong evidence that doxycycline treatment may be an effective strategy against synucleinopathies. Fil: Dominguez Meijide, Antonio. Universidad de Santiago de Compostela; España Fil: Parrales, Valeria. Sorbonne University; Francia Fil: Vasili, Eftychia. University Medical Center Goettingen; Alemania Fil: González Lizarraga, Maria Florencia. Universidad Nacional de Tucumán. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucumán. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario; Argentina Fil: König, Annekatrin. University Medical Center Goettingen; Alemania Fil: Lázaro, Diana F.. University Medical Center Goettingen; Alemania Fil: Lannuzel, Annie. Sorbonne University; Francia Fil: Haik, Stéphane. Sorbonne University; Francia Fil: del Bel Belluz Guimaraes, Elaine. Universidade de Sao Paulo; Brasil Fil: Chehin, Rosana Nieves. Universidad Nacional de Tucumán. Instituto de Investigaciones En Medicina Molecular y Celular Aplicada del Bicentenario. - Gobierno de la Provincia de Tucumán. Ministerio de Salud. Sistema Provincial de Salud. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario. - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Investigaciones en Medicina Molecular y Celular Aplicada del Bicentenario; Argentina Fil: Raisman Vozari, Rita. Sorbonne University; Francia Fil: Michel, Patrick P.. Sorbonne University; Francia Fil: Bizat, Nicolas. Sorbonne University; Francia Fil: Outeiro, Tiago Fleming. University Medical Center Goettingen; Alemania |
description |
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are neurodegenerative disorders characterized by the misfolding and aggregation of alpha-synuclein (aSyn). Doxycycline, a tetracyclic antibiotic shows neuroprotective effects, initially proposed to be due to its anti-inflammatory properties. More recently, an additional mechanism by which doxycycline may exert its neuroprotective effects has been proposed as it has been shown that it inhibits amyloid aggregation. Here, we studied the effects of doxycycline on aSyn aggregation in vivo, in vitro and in a cell free system using real-time quaking induced conversion (RT-QuiC). Using H4, SH-SY5Y and HEK293 cells, we found that doxycycline decreases the number and size of aSyn aggregates in cells. In addition, doxycycline inhibits the aggregation and seeding of recombinant aSyn, and attenuates the production of mitochondrial-derived reactive oxygen species. Finally, we found that doxycycline induces a cellular redistribution of aggregates in a C.elegans animal model of PD, an effect that is associated with a recovery of dopaminergic function. In summary, we provide strong evidence that doxycycline treatment may be an effective strategy against synucleinopathies. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/172383 Dominguez Meijide, Antonio; Parrales, Valeria; Vasili, Eftychia; González Lizarraga, Maria Florencia; König, Annekatrin; et al.; Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo; Academic Press Inc Elsevier Science; Neurobiology of Disease; 151; 4-2021; 1-19 0969-9961 1095-953X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/172383 |
identifier_str_mv |
Dominguez Meijide, Antonio; Parrales, Valeria; Vasili, Eftychia; González Lizarraga, Maria Florencia; König, Annekatrin; et al.; Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo; Academic Press Inc Elsevier Science; Neurobiology of Disease; 151; 4-2021; 1-19 0969-9961 1095-953X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.nbd.2021.105256 info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S096999612100005X |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Academic Press Inc Elsevier Science |
publisher.none.fl_str_mv |
Academic Press Inc Elsevier Science |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269586420924416 |
score |
13.13397 |